The Catalan biotechnology company Allox has closed a funding round of 10.5 million dollars (about 9.4 million euros) led by Asabys, through its fund Sabadell Asabys II. Also participating were the CDTI –the center for technological development of the Ministry of Science, Innovation and Universities– and the Catalan Institute of Finance (ICF), the public financial entity of the Generalitat.